On April 12, 2023 the White House officially designated fentanyl adulterated or associated with xylazine as an emerging threat to the U.S.

Xylazine is a veterinary sedative with no approval for human use and is increasingly present in overdose deaths in the United States, compounding the overdose crisis.

California healthcare providers and community-based organizations serving people who use drugs should be vigilant for the presence of xylazine.

Please see the full CDPH Health Advisory, including recommendations for healthcare providers here:
https://www.cdph.ca.gov/Programs/OPA/Pages/CAHAN/Xylazine-in-Illicit-Fentanyl-in-the-United-States.aspx

More:

• FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs 11-8-22

Free viewers are required for some of the attached documents.
They can be downloaded by clicking on the icons below.

Acrobat Reader Windows Media Player Word Viewer Excel Viewer PowerPoint Viewer